Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Receives DEQAS Certification for Vitamin D Testing

NEW YORK (GenomeWeb News) – Warnex today announced its Bioanalytical Services division participated in the International External Quality Assessment Scheme, or DEQAS, and received DEQAS certification for the analysis of Vitamin D (25-hydroxyvitamin D.)

Analysis of 25-hydroxyvitamin D is one of the most accurate testing methods of Vitamin D in the body, Warnex said, and its participation in DEQAS demonstrated the reliability of its method in terms of absolute values, assay linearity, and assay precision. Warnex's method of analysis combines high-performance liquid chromatography and mass spectrometry to measure 25-hydroxyvitamin D2 and D3 in plasma.

Vitamin D deficiency has been linked to rickets in children and osteomalacia and osteoporosis in adults, as well as certain cancers, type 1 diabetes, Alzheimer's, and other illnesses.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.